In three new studies that could redefine how cancer is viewed, researched, and treated, scientists have created a detailed map of the genetic mutations that underlie two of the deadliest forms of the disease: pancreatic cancer and glioblastoma, the type of brain tumor that Senator Edward Kennedy was diagnosed with this past spring. The new ...

 This image shows the active site of the IDH1 enzyme. Scientists have discovered that mutations in the gene encoding this enzyme are found in the tumors of patients with the brain cancer glioblastoma. Credit: Parsons et al

BOISE, Idaho — Researchers at Boise State University say they have used emerging nanotechnology techniques to devise a way to kill cancer cells while leaving normal cells healthy. Biology professor Denise Wingett said that many cancer drugs target rapidly dividing cells, but can leave people sick because the dose is also toxic to ...

In the not-so-distant future, these six drugs--already in the works--will change how we live, and even how we die. See articles on:Cancer VaccineMale Birth Control PillAnti-Addiction PillExercise PillAnti-Aging PillSmart Pill Read Story...

Devils Lake, ND businesswoman Rose Wilhelmi may be back on the job by the end of the year. The owner of Rose’s Stitch & Sew on main street has been undergoing cancer treatment since early spring, and will undergo a stem cell transplant today at Mayo Clinic in Rochester, Minn. The transplant will come courtesy her family and start ...

When a cell begins to multiply in a dangerously abnormal way, a series of death signals trigger it to self-destruct before it turns cancerous. Now, in research to appear in the August 15 issue of Genes & Development, Rockefeller University scientists have figured out a way in mice to amplify the signals that tell these precancerous cells to ...

Platinum-based anticancer agents have a long history as proven therapeutic agents, but their toxicity and short lifetime in the body and the ability of tumors to develop resistance to these drugs limit the ultimate utility of these agents. In an attempt to overcome these limitations, a multi-institutional research team comprising ...

The Institute for NanoBioTechnology (INBT) has recently launched a postdoctoral fellowship in Nanotechnology for Cancer Medicine (NTCM). Funded by the National Cancer Institute, the goal of this new postdoctoral training program is to ensure that a diverse and highly trained workforce is available to assume leadership roles in biomedical, ...

For Rickey Turner and the Rev. Tom Roberson, the debate about stem cell treatment is personal. Both have received adult stem cell treatments — not the more controversial embryonic stem cell treatment.For Turner, a former Henderson police lieutenant, adult stem cell treatment helped him regain some movement in his body after a wreck ...